Sangers Sequencing Service Market by Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others) and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics) - Global Opportunity Analysis and Industry Forecast, 2013-2025
Sanger’s sequencing method is based on the principle of detecting labelled chain-terminating nucleotides, which are incorporated by a DNA polymerase during the replication of a template. This method of sequencing is also known as chain termination or dideoxy sequencing. The global Sanger’s sequencing service market was valued at $192 million in 2013, and is estimated to reach at $1,085 million by 2025, registering a CAGR of 14.2% from 2018 to 2025.
As Sanger’s sequencing is known as the gold standard of sequencing technologies, as it offers long read capability and a high-degree of accuracy. Sanger’s sequencing services are routinely offered by sequencing companies to different end users such as academic institutes and hospitals for sequence analysis.
Advantages associated with Sanger’s sequencing, technological advancements in sequencing procedures, and surge in application of Sanger’s sequencing are the key factors that boost market growth. Furthermore, increase in genome mapping programs; rise in awareness pertaining to DNA sequencing; and increase in investment in research, development, & innovation have bolstered the market growth.
However, dearth of skilled professionals and standardization concerns in sequencing procedures impede the market growth. Conversely, the use of cloud computing as a potential data management service and high growth potential in untapped emerging countries are anticipated to offer lucrative opportunities for market players in the near future.
The Sanger’s sequencing service market is segmented based on application, end user, and region. By application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and other applications. Deepening on end user, it is fragmented into academic & government research institutes, pharmaceuticals companies, biotechnology companies and hospitals & clinics. Region wise, the market is classified into the following regions, namely, the United States, EU, Japan, China, India, Southeast Asia, and rest of the world (ROW).
KEY BENEFITS •This report entails a detailed quantitative analysis of the current market trends and future estimations from 2013 to 2025 to identify the prevailing opportunities. •Sanger’s sequencing service market size and market estimations are based on comprehensive analysis of the applications, end users, and developments in the industry. •In-depth analysis based on region assists to understand the regional market and the strategic business planning. •The development strategies adopted by key market players are enlisted to understand the competitive scenario of the market
KEY MARKET SEGMENTS
By Application •Diagnostics •Biomarkers & Cancer •Reproductive Health •Personalized Medicine •Forensics •Others
By End User •Academic & Government Research Institutes •Pharmaceutical Companies •Biotechnology Companies •Hospitals & Clinics
By Region •United States •EU •Japan •China •India •Southeast Asia •Rest of the World (ROW)
The list of key players operating in this market includes: •Source BioScience •GenScript Biotech Corporation •Thermo Fisher Scientific, Inc. •LGC Science Group Limited •Fasteris SA •CeMIA SA •Quintara Biosciences •GenHunter Corporation •Eurofins Scientific SE •GENEWIZ •Nucleics •SciGenom Labs Pvt. Limited •Microsynth AG. Inc.
The other players included in the value chain analysis (and not included in the report) include: •Laragen, Inc. •StarSEQ GmbH
Our reports have been used by over 10K customers, including:
479 pages •
By Global Industry Analysts
• May 2021
Global Collagen Peptides Market to Reach $822.9 Million by 2027
Amid the COVID-19 crisis, the global market for Collagen Peptides estimated at US$564.4 Million in the year 2020, is projected to reach a revised size of US$822.9 Million by 2027, growing at a CAGR of 5.5% over the analysis...
This IDC Perspective provides IDC Health Insights' overview of key IT deals, news, and digital initiatives in the European life sciences and pharma industries in Q1 2021. In the evolving COVID-19 scenario, it is critical for European life sciences companies and their technology suppliers to closely follow the fast-moving trends and developments...
130 pages •
By Global Industry Analysts
• Apr 2021
- Global Cell Separation Technologies Market to Reach $5.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Cell Separation Technologies estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2027, growing at a CAGR of 8.1% over the analysis...
The global microplate systems market size is projected to reach USD 1,170 million by 2026 from USD 927 million in 2021, at a CAGR of 4.8% from 2021 to 2026. Growth in this market is driven by the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, and the growing prevalence of diseases Microplate...
The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This report provides...
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of distribution agreements from...
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2021 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The report provides a detailed understanding and analysis of how and why companies enter business, product,...
The Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.